2 months ResMed (RMD) Surpasses Q1 Earnings and Revenue Estimates Zacks
ResMed (RMD) delivered earnings and revenue surprises of 8.37% and 2.98%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
X